These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18335777)

  • 1. From scandal to stardom: how Merck healed itself.
    Simons J
    Fortune; 2008 Feb; 157(3):94-6, 98. PubMed ID: 18335777
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it too late to save Schering?
    Simons J
    Fortune; 2003 Sep; 148(5):145-6, 148, 150. PubMed ID: 14509911
    [No Abstract]   [Full Text] [Related]  

  • 3. Does your corporate culture contribute to the problem?
    Desjardins RE
    Food Drug Law J; 1997; 52(2):169-71. PubMed ID: 10557554
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing organizational interfaces.
    Allen TJ
    Food Drug Law J; 1997; 52(2):173-7. PubMed ID: 10557555
    [No Abstract]   [Full Text] [Related]  

  • 5. PhRMA wants you!
    Nat Biotechnol; 2010 Feb; 28(2):103. PubMed ID: 20139926
    [No Abstract]   [Full Text] [Related]  

  • 6. Pessimistic response to FDA leadership change.
    Kling J
    Nat Biotechnol; 2005 Nov; 23(11):1325. PubMed ID: 16273044
    [No Abstract]   [Full Text] [Related]  

  • 7. An impossible job.
    Nat Biotechnol; 2005 Nov; 23(11):1321. PubMed ID: 16273042
    [No Abstract]   [Full Text] [Related]  

  • 8. Working together to enhance the efficiency of medical product development.
    Sanhai WR
    J Nucl Med; 2008 Jun; 49(6):43N-45N. PubMed ID: 18511823
    [No Abstract]   [Full Text] [Related]  

  • 9. A new CEO'S RX for what ails Merck.
    Simons J
    Fortune; 2005 May; 151(11):28. PubMed ID: 15926519
    [No Abstract]   [Full Text] [Related]  

  • 10. Will R&D make Merck hot again?
    Simons J
    Fortune; 2002 Jul; 146(1):89-90, 92, 94. PubMed ID: 12119729
    [No Abstract]   [Full Text] [Related]  

  • 11. Miracles in the making: the story behind the success of Children's Miracle Network.
    Cook RH
    Fund Raising Manage; 2000 Sep; 31(7):10-3, 35. PubMed ID: 11185267
    [No Abstract]   [Full Text] [Related]  

  • 12. Public Relations: Ketchum brands new product with innovative PR strategy.
    Profiles Healthc Commun; 2006; 22(5):11-4, 2. PubMed ID: 17048759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Showing them evidence.
    Hagland M
    Healthc Inform; 2011 Jun; 28(6):54-5. PubMed ID: 21736213
    [No Abstract]   [Full Text] [Related]  

  • 14. Abbreviated approval process in the works for 'biosimilar' drugs.
    Sipkoff M
    Manag Care; 2007 Apr; 16(4):52, 55. PubMed ID: 17491291
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharma in-licensing 2007--cost versus paucity.
    Williams M
    Curr Opin Investig Drugs; 2007 Jan; 8(1):17-24. PubMed ID: 17263181
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney scandal at Kaiser Permanente highlights need for organizations to create effective image repair strategies.
    Johnson RL
    Health Care Strateg Manage; 2006 Nov; 24(11):14-6. PubMed ID: 17153667
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory watch: FDA PDUFA goals missed.
    Hay M
    Nat Rev Drug Discov; 2009 Jan; 8(1):10. PubMed ID: 19116619
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving productivity with model-based drug development: an enterprise perspective.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2010 Aug; 88(2):263-8. PubMed ID: 20592720
    [No Abstract]   [Full Text] [Related]  

  • 19. The advantages of a public relations firm in achieving the goals of the American College of Gastroenterology.
    Bakal C; Blicksilver O
    Am J Gastroenterol; 1982 Feb; 77(2):122-5. PubMed ID: 7072680
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical organizations and their relationships to public affairs. 1957.
    Allman DB
    Conn Med; 2007 Aug; 71(7):427-30. PubMed ID: 17879866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.